Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000103

Chief Financial Officer gave up 1,102 shares (to pay taxes)

  • Chief Financial Officer acquired 3,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Adams Kendra Chief Financial Officer 2024-11-07 Option exercise +3,750 85,541 D
Adams Kendra Chief Financial Officer 2024-11-07 Shares withheld for taxes −1,102 $6.04 $6,656 84,439 D
Derivatives
Adams Kendra Chief Financial Officer 2024-11-07 Option exercise · Performance Restricted Stock Units −3,750 10,500 D
Loading xslF345X05/wk-form4_1731446246.xml…